Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
8.3%
% of XLV's 60 holdings also in OZEM
20.8%
% of OZEM's 25 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.3% | 17.7% | 12.3% |
|
AMGEN INC | 3.1% | 4.7% | 3.1% |
|
PFIZER INC | 2.7% | 3.7% | 2.7% |
|
GILEAD SCIENCES INC | 2.6% | 2.7% | 2.6% |
|
REGENERON PHARMACEUTICALS | 1.3% | 2.4% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 9.0% |
|
JOHNSON & JOHNSON | 7.5% |
|
ABBVIE INC | 6.9% |
|
ABBOTT LABORATORIES | 4.3% |
|
MERCK & CO. INC. | 4.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
INTUITIVE SURGICAL INC | 3.3% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
|
DANAHER CORP | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.4% |
XLV Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -12.7% |
 |
ROCHE HOLDING LTD | -6.5% |
|
ELI LILLY & CO | -5.4% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.2% |
 |
INNOVENT BIOLOGICS, INC. | -4.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.8% |
|
ZEALAND PHARMA A/S | -3.9% |
 |
HANMI PHARM CO LTD | -2.9% |
 |
THE UNITED LABORATORIES INTE | -2.7% |
|
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.4% |